ImmunityBio, Inc. IBRX Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s accretion (amortization) of discounts and premiums, investments?
- ImmunityBio, Inc. (IBRX) reported accretion (amortization) of discounts and premiums, investments of $1.53M in Q1 2026.
- How has ImmunityBio, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
- ImmunityBio, Inc.'s accretion (amortization) of discounts and premiums, investments increased by 2834.6% year-over-year, from $52K to $1.53M.
- What is the long-term trend for ImmunityBio, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Over 3 years (2021 to 2025), ImmunityBio, Inc.'s accretion (amortization) of discounts and premiums, investments has grown at a 89.6% compound annual growth rate (CAGR), from -$403K to $2.75M.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This represents the non-cash adjustment to the carrying value of investment securities purchased at a discount or premium. It ensures that the interest income recognized reflects the effective yield of the investment over its holding period.